Clinical Nurse Specialist Neuromuscular IVIg and Immunosuppression

The successful individual will have a pivotal role in delivering Trust Objectives and ensuring that the care delivered within this specialty reflects the Trust Vision and Values. If you are passionate about patient care and have the ability to work effectively within a team in forward thinking and innovative learning environments, we would like to hear from you. We offer you diverse, varied experiences to expand and extend your knowledge and skills, tailored to meet individual needs in your developing career pathway. We believe in maintaining high standards in everything we do so bring your ideas, enthusiasm and motivation to raise the bar and give expert care to all our patients. This is an exciting opportunity to work collaboratively with all professional groups, offering you the combination of specialist nursing with hands on care.

We are looking for someone with excellent clinical acute care skills who can work alongside staff to transfer this knowledge and skill set.

University College London Hospitals NHS Foundation Trust (UCLH) is one of the most complex NHS trusts in the UK, serving a large and diverse population. We provide academically led acute and specialist services, to people from the local area, from throughout the United Kingdom and overseas. Our vision is to deliver top-quality patient care, excellent education, and world-class research. We provide first-class acute and specialist services across eight sites:

• University College Hospital (incorporating the Elizabeth Garrett Anderson Wing), We are dedicated to the diagnosis and treatment of many complex illnesses. UCLH specialises in women's health and the treatment of cancer, infection, neurological, gastrointestinal and oral disease. It has world class support services including critical care, imaging, nuclear medicine and pathology.
We are committed to sustainability and have pledged to become a carbon net zero health service, embedding sustainable practice throughout UCLH. We have set an ambitious target of net zero for our direct emissions by 2031 and indirect emissions by 2040.